Proteinuria
7 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Narrower: Albuminuria 3
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| ARBs in combination of SGLT2i for proteinuria | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Atrasentan for proteinuria | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Iptacopan for proteinuria | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| JADE101 for proteinuria | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD for albuminuria | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo + SOTAGLIFLOZIN for albuminuria | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo QD + SGLT2i QD, Washout, Lorundrostat 25mg+SGLT2i QD for albuminuria | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.